| KRAS and the reality of personalized medicine in non-small cell lung cancer HO Kilgoz, G Bender, JM Scandura, A Viale, B Taneri Molecular Medicine 22, 380-387, 2016 | 19 | 2016 |
| Immunomodulatory effects of exosomes: Promising candidates in immunotherapy HÖ Kılgöz PQDT-Global, 2018 | 1 | 2018 |
| Potential Use of Human Mesenchymal Stem Cells (hMSCs) in Pancreatic Damage/Cancer HÖ Eyüpoğlu, E Eyüpoğlu, N Serakinci OBM Genetics 8 (3), 1-18, 2024 | | 2024 |
| TUBA1C: a potential biomarker for Type II Diabetes Mellitus (T2D) associated cancer E Eyupoglu, HO Eyupoglu, S Tuzmen EUROPEAN JOURNAL OF HUMAN GENETICS 32, 293-293, 2024 | | 2024 |
| the potential of mummy substance to stimulate healing in mesenchymal stem cells cultured with human fibroblasts SH Khodaei, S Sabetkam, HO Eyupoglu, S Tuzmen EUROPEAN JOURNAL OF HUMAN GENETICS 32, 136-136, 2024 | | 2024 |
| Regulation of tumor microenvironment (TME) of pancreatic cancer: a mechanistic insight for potential tumor immunotherapeutics HO Eyupoglu, E Eyupoglu, S Tuzmen EUROPEAN JOURNAL OF HUMAN GENETICS 32, 293-293, 2024 | | 2024 |
| Carnosic acid as potential anti-SARS-CoV-2 therapeutics: a mechanistic insight. HO Kilgoz, E Eyupoglu, S Hassanpour Khodaei, S Tuzmen Eur. J. of Hum. Gen. 31 (1), 2023 | | 2023 |
| Stem cell-derived exosome signature reveals immunoregulatory phenotype through downregulation of prostaglandin E synthase (PTGES) HO Eyupoglu, E Eyupoglu, N Serakinci, S Tuzmen FEBS Open Bio 13 (2), 2023 | | 2023 |
| Clinical Trials of COVID-19 Therapeutics and Vaccines: History, Current Status, and Limitations CH Perry, HÖ Kılgöz, Ş Tüzmen COVID-19, 181-195, 2022 | | 2022 |
| Exosome: an emerging participant in liver disease progression. HO Kilgoz, SS Ozcan, H Gokcan, N Yilmaz, H Ataseven, M Akdogan, ... Eur. J. Immunol. 51 (P-1049), 1-448, 2021 | | 2021 |
| The Role of Exosomes in Immunity to Infections and in Protection from Infections SS Ozcan, HO Kilgoz, I Gursel. The Role of Exosomes in the Pathogenesis and Diagnosis of Infectious …, 2018 | | 2018 |
| Clinical Trials of COVID-19 Therapeutics and Vaccines: History, Current Status, and Limitations CH Perry, HÖ Kılgöz, Ş Tüzmen COVID-19: From Bench to Bedside (1st ed.), 181-195, 0 | | |
